Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genomewide significant breast cancer locus at 12q15.

Madsen MJ, Knight S, Sweeney C, Factor RE, Salama ME, Stijleman IJ, Rajamanickam V, Welm BE, Arunachalam S, Jones B, Rachamadugu R, Rowe K, Cessna M, Thomas A, Kushi LH, Caan B, Bernard PS, Camp NJ.

Cancer Epidemiol Biomarkers Prev. 2018 Apr 12. pii: cebp.0887.2017. doi: 10.1158/1055-9965.EPI-17-0887. [Epub ahead of print]

PMID:
29650789
2.

Evaluation of the SharkCore® needle for EUS-guided core biopsy of pancreatic neuroendocrine tumors.

Witt BL, Factor RE, Chadwick BE, Caron J, Siddiqui AA, Adler DG.

Endosc Ultrasound. 2018 Apr 4. doi: 10.4103/eus.eus_51_17. [Epub ahead of print]

3.

Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes.

Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, Reddy CB, Boltax JP, Li DY, Moos PJ, Gray JW, Heiser LM, Buys SS, Cohen AL, Johnson WE, Quinlan AR, Marth G, Werner TL, Bild AH.

Nat Commun. 2018 Feb 5;9(1):572. doi: 10.1038/s41467-017-02383-6.

4.

BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism.

Vázquez-Arreguín K, Maddox J, Kang J, Park D, Cano RR, Factor RE, Ludwig T, Tantin D.

Mol Cancer Res. 2018 Mar;16(3):439-452. doi: 10.1158/1541-7786.MCR-17-0364. Epub 2018 Jan 12.

PMID:
29330289
5.

Combating subclonal evolution of resistant cancer phenotypes.

Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, Reddy CB, Boltax JP, Li DY, Moos PJ, Gray JW, Heiser LM, Buys SS, Cohen AL, Johnson WE, Quinlan AR, Marth G, Werner TL, Bild AH.

Nat Commun. 2017 Nov 1;8(1):1231. doi: 10.1038/s41467-017-01174-3. Erratum in: Nat Commun. 2018 Feb 5;9(1):572.

6.

HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.

Stewart RL, Caron JE, Gulbahce EH, Factor RE, Geiersbach KB, Downs-Kelly E.

Mod Pathol. 2017 Nov;30(11):1561-1566. doi: 10.1038/modpathol.2017.65. Epub 2017 Jul 28.

PMID:
28752841
7.

X-Ray of Excised Cancerous Breast Tissue Does Not Affect Clinical Biomarker Expression.

Lloyd IE, Welm AL, DeRose Y, Neumayer LA, Kohan JL, Malmberg EM, Salama ME, Factor RE.

Appl Immunohistochem Mol Morphol. 2017 Feb 9. doi: 10.1097/PAI.0000000000000454. [Epub ahead of print]

PMID:
28187031
8.

An unexpected diagnosis of ectopic liver diagnosed by fine needle aspiration.

Barazza G, Adler DG, Factor RE.

Cytojournal. 2016 Dec 20;13:29. doi: 10.4103/1742-6413.196239. eCollection 2016.

9.

Statistical Literacy Among Academic Pathologists: A Survey Study to Gauge Knowledge of Frequently Used Statistical Tests Among Trainees and Faculty.

Schmidt RL, Chute DJ, Colbert-Getz JM, Firpo-Betancourt A, James DS, Karp JK, Miller DC, Milner DA Jr, Smock KJ, Sutton AT, Walker BS, White KL, Wilson AR, Wojcik EM, Yared MA, Factor RE.

Arch Pathol Lab Med. 2017 Feb;141(2):279-287. doi: 10.5858/arpa.2016-0200-OA. Epub 2016 Dec 13.

PMID:
27959584
10.

POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen.

Cohen AL, Factor RE, Mooney K, Salama ME, Wade M, Serpico V, Ostrander E, Nelson E, Porretta J, Matsen C, Bernard P, Boucher K, Neumayer L.

Breast. 2017 Feb;31:219-223. doi: 10.1016/j.breast.2016.11.016. Epub 2016 Dec 6.

11.

The molecular basis of breast cancer pathological phenotypes.

Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH.

J Pathol. 2017 Feb;241(3):375-391. doi: 10.1002/path.4847. Epub 2016 Dec 29.

12.

Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus.

Camp NJ, Lin WY, Bigelow A, Burghel GJ, Mosbruger TL, Parry MA, Waller RG, Rigas SH, Tai PY, Berrett K, Rajamanickam V, Cosby R, Brock IW, Jones B, Connley D, Sargent R, Wang G, Factor RE, Bernard PS, Cannon-Albright L, Knight S, Abo R, Werner TL, Reed MW, Gertz J, Cox A.

Cancer Res. 2016 Apr 1;76(7):1916-25. doi: 10.1158/0008-5472.CAN-15-1629. Epub 2016 Jan 21.

13.

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA; TCGA Research Network, Perou CM.

Cell. 2015 Oct 8;163(2):506-19. doi: 10.1016/j.cell.2015.09.033.

14.

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Kwan ML, Bernard PS, Kroenke CH, Factor RE, Habel LA, Weltzien EK, Castillo A, Gunderson EP, Maxfield KS, Stijleman IJ, Langholz BM, Quesenberry CP Jr, Kushi LH, Sweeney C, Caan BJ.

J Natl Cancer Inst. 2015 Apr 28;107(7). pii: djv087. doi: 10.1093/jnci/djv087. Print 2015 Jul.

15.

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression.

Kwan ML, Kroenke CH, Sweeney C, Bernard PS, Weltzien EK, Castillo A, Factor RE, Maxfield KS, Stijleman IJ, Kushi LH, Quesenberry CP Jr, Habel LA, Caan BJ.

BMC Cancer. 2015 Apr 14;15:278. doi: 10.1186/s12885-015-1263-4.

16.

Researchers should be aware of partial verification bias in diagnostic accuracy studies.

Schmidt RL, Factor RE.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 May;119(5):593. doi: 10.1016/j.oooo.2014.11.027. Epub 2015 Feb 14. No abstract available.

PMID:
25864821
17.

Quantitative Assessment of Multiorgan Sequestration of Parasites in Fatal Pediatric Cerebral Malaria.

Milner DA Jr, Lee JJ, Frantzreb C, Whitten RO, Kamiza S, Carr RA, Pradham A, Factor RE, Playforth K, Liomba G, Dzamalala C, Seydel KB, Molyneux ME, Taylor TE.

J Infect Dis. 2015 Oct 15;212(8):1317-21. doi: 10.1093/infdis/jiv205. Epub 2015 Apr 7.

18.

Axillary lymph node FNA in women with breast cancer is a highly accurate procedure, so why are core biopsies being done?

Factor RE, Schmidt RL, Chadwick BE, Witt BJ, Morgan M, Neumayer LA, Layfield LJ.

Diagn Cytopathol. 2015 Jun;43(6):510-2. doi: 10.1002/dc.23251. Epub 2015 Jan 28. No abstract available.

PMID:
25631215
19.

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.

Kroenke CH, Sweeney C, Kwan ML, Quesenberry CP, Weltzien EK, Habel LA, Castillo A, Bernard PS, Factor RE, Kushi LH, Caan BJ.

Breast Cancer Res Treat. 2014 Apr;144(3):689-99. doi: 10.1007/s10549-014-2899-5. Epub 2014 Mar 7.

20.

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes.

Caan BJ, Sweeney C, Habel LA, Kwan ML, Kroenke CH, Weltzien EK, Quesenberry CP Jr, Castillo A, Factor RE, Kushi LH, Bernard PS.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):725-34. doi: 10.1158/1055-9965.EPI-13-1017. Epub 2014 Feb 12.

21.

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.

Sweeney C, Bernard PS, Factor RE, Kwan ML, Habel LA, Quesenberry CP Jr, Shakespear K, Weltzien EK, Stijleman IJ, Davis CA, Ebbert MT, Castillo A, Kushi LH, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):714-24. doi: 10.1158/1055-9965.EPI-13-1023. Epub 2014 Feb 12.

22.

Diagnostic accuracy studies of fine-needle aspiration show wide variation in reporting of study population characteristics: implications for external validity.

Schmidt RL, Narra KK, Witt BL, Factor RE.

Arch Pathol Lab Med. 2014 Jan;138(1):88-97. doi: 10.5858/arpa.2013-0036-OA.

PMID:
24377815
23.

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher D, Sutter C, Wang-Gohrke S, Steinemann D, Preisler-Adams S, Kast K, Varon-Mateeva R, Ellis S, Frost D, Platte R, Perkins J, Evans DG, Izatt L, Eeles R, Adlard J, Davidson R, Cole T, Scuvera G, Manoukian S, Bonanni B, Mariette F, Fortuzzi S, Viel A, Pasini B, Papi L, Varesco L, Balleine R, Nathanson KL, Domchek SM, Offitt K, Jakubowska A, Lindor N, Thomassen M, Jensen UB, Rantala J, Borg Å, Andrulis IL, Miron A, Hansen TV, Caldes T, Neuhausen SL, Toland AE, Nevanlinna H, Montagna M, Garber J, Godwin AK, Osorio A, Factor RE, Terry MB, Rebbeck TR, Karlan BY, Southey M, Rashid MU, Tung N, Pharoah PD, Blows FM, Dunning AM, Provenzano E, Hall P, Czene K, Schmidt MK, Broeks A, Cornelissen S, Verhoef S, Fasching PA, Beckmann MW, Ekici AB, Slamon DJ, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Flesch-Janys D, Rudolph A, Seibold P, Aittomäki K, Muranen TA, Heikkilä P, Blomqvist C, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Olson JE, Pankratz VS, John EM, Whittemore AS, West DW, Hamann U, Torres D, Ulmer HU, Rüdiger T, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ, Eccles DM, Tapper WJ, Durcan L, Jones L, Peto J, dos-Santos-Silva I, Fletcher O, Johnson N, Dwek M, Swann R, Bane AL, Glendon G, Mulligan AM, Giles GG, Milne RL, Baglietto L, McLean C, Carpenter J, Clarke C, Scott R, Brauch H, Brüning T, Ko YD, Cox A, Cross SS, Reed MW, Lubinski J, Jaworska-Bieniek K, Durda K, Gronwald J, Dörk T, Bogdanova N, Park-Simon TW, Hillemanns P, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Burwinkel B, Marme F, Surovy H, Yang R, Anton-Culver H, Ziogas A, Hooning MJ, Collée JM, Martens JW, Tilanus-Linthorst MM, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Lindblom A, Margolin S, Joseph V, Robson M, Rau-Murthy R, González-Neira A, Arias JI, Zamora P, Benítez J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Peterlongo P, Zaffaroni D, Barile M, Capra F, Radice P, Teo SH, Easton DF, Antoniou AC, Chenevix-Trench G, Goldgar DE; ABCTB Investigators; EMBRACE Group; GENICA Network; HEBON Group; kConFab Investigators.

Breast Cancer Res. 2014 Dec 23;16(6):3419. doi: 10.1186/s13058-014-0474-y.

24.

Invasive carcinoma with acinic cell-like features of the breast.

Winkler N, Morrell G, Factor RE.

Breast J. 2013 May-Jun;19(3):334-5. doi: 10.1111/tbj.12119. Epub 2013 Apr 18. No abstract available.

PMID:
23600952
25.

Quality appraisal of diagnostic accuracy studies in fine-needle aspiration cytology: a survey of risk of bias and comparability.

Schmidt RL, Factor RE, Witt BL, Layfield LJ.

Arch Pathol Lab Med. 2013 Apr;137(4):566-75. doi: 10.5858/arpa.2012-0199-RA. Review.

PMID:
23544946
26.

Understanding sources of bias in diagnostic accuracy studies.

Schmidt RL, Factor RE.

Arch Pathol Lab Med. 2013 Apr;137(4):558-65. doi: 10.5858/arpa.2012-0198-RA. Review.

PMID:
23544945
27.

Needle size has only a limited effect on outcomes in EUS-guided fine needle aspiration: a systematic review and meta-analysis.

Affolter KE, Schmidt RL, Matynia AP, Adler DG, Factor RE.

Dig Dis Sci. 2013 Apr;58(4):1026-34. doi: 10.1007/s10620-012-2439-2. Epub 2012 Oct 21. Review.

PMID:
23086117
28.
29.

Clinician compliance with laboratory regulations requiring submission of relevant clinical data: A one year retrospective analysis.

Layfield LJ, Factor RE, Jarboe EA.

Pathol Res Pract. 2012 Nov 15;208(11):668-71. doi: 10.1016/j.prp.2012.08.005. Epub 2012 Sep 19.

PMID:
22999368
30.

The nuclear envelope environment and its cancer connections.

Chow KH, Factor RE, Ullman KS.

Nat Rev Cancer. 2012 Feb 16;12(3):196-209. doi: 10.1038/nrc3219. Review.

31.

Methods specification for diagnostic test accuracy studies in fine-needle aspiration cytology: a survey of reporting practice.

Schmidt RL, Factor RE, Affolter KE, Cook JB, Hall BJ, Narra KK, Witt BL, Wilson AR, Layfield LJ.

Am J Clin Pathol. 2012 Jan;137(1):132-41. doi: 10.1309/AJCPQX1KBJ2PZJFK.

PMID:
22180487
32.

High-frequency ultrasound for intraoperative margin assessments in breast conservation surgery: a feasibility study.

Doyle TE, Factor RE, Ellefson CL, Sorensen KM, Ambrose BJ, Goodrich JB, Hart VP, Jensen SC, Patel H, Neumayer LA.

BMC Cancer. 2011 Oct 12;11:444. doi: 10.1186/1471-2407-11-444.

33.

Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4.

Powers MA, Fay MM, Factor RE, Welm AL, Ullman KS.

Cancer Res. 2011 Aug 15;71(16):5579-87. doi: 10.1158/0008-5472.CAN-11-0458. Epub 2011 Jun 23.

34.

Fine-needle aspiration diagnosis of an intraosseous amyloidoma.

Factor RE, Layfield LJ, Grossmann AH, Crim JR, Price SL, Randall RL.

Diagn Cytopathol. 2012 Aug;40 Suppl 2:E114-7. doi: 10.1002/dc.21686. Epub 2011 May 4.

PMID:
21548115
35.

Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies.

Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM.

Acad Radiol. 2009 Nov;16(11):1408-15. doi: 10.1016/j.acra.2009.06.008. Epub 2009 Aug 15.

PMID:
19683945
36.

Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma.

Factor RE, Dal Cin P, Fletcher JA, Cibas ES.

Cancer. 2009 Aug 25;117(4):247-53. doi: 10.1002/cncy.20036.

37.

Photo quiz. An HIV-infected man with an upset stomach.

Asmal M, Factor RE, Walensky RP.

Clin Infect Dis. 2008 Oct 1;47(7):935-6; 979-80. doi: 10.1086/591694. No abstract available.

PMID:
18778229
38.

Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.

Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.

Eur J Immunol. 1998 Oct;28(10):3128-36.

PMID:
9808181

Supplemental Content

Loading ...
Support Center